Source: Contract Pharma

FLUIDDA: Aptar Expands Pharmaceutical Services

Forms collaboration with Fluidda, accelerating regulatory athway for orally inhaled products.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jan De Backer's photo - CEO of FLUIDDA

CEO

Jan De Backer

CEO Approval Rating

90/100

Read more